Cyprotex has appointed Dr Monica Metea as director of US Operations. The role, which commences today, will provide operational and scientific leadership to the two Cyprotex facilities in the US at Watertown, MA and Kalamazoo, MI.
Prior to joining Cyprotex, Metea held senior roles at WIL Research Laboratories LLC (recently acquired by Charles River Laboratories International Inc), Covance Laboratories Inc, and most recently Smithers Viscient where she held a director's position.
Metea has been awarded a PhD in Neuroscience from the University of Minnesota. She is a recognised expert consultant in preclinical electrophysiology and drug safety, and has a strong background in safety pharmacology and toxicology.
(LON:CRX) Cyprotex PLC share price was -2.5p at 143.5p